BioMarin Pharmaceutical, Inc. (BMRN)
53.28
-0.02
(-0.04%)
USD |
NASDAQ |
Dec 09, 12:50
BioMarin Pharmaceutical Shareholders Equity (Quarterly): 6.057B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Align Technology, Inc. | 3.957B |
| Biogen, Inc. | 18.21B |
| Gilead Sciences, Inc. | 21.54B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.615B |
| Total Liabilities (Quarterly) | 1.558B |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 4.828 |
| Net Debt Paydown Yield | 0.94% |